Incannex: Recently US-based developer of Cannabinoid Therapeutics (NASDAQ:IXHL)

Michael Fischer

Incannex Healthcare Inc. (NASDAQ:IXHL) is a developer of medicinal cannabinoid and psychedelic pharmaceutical product candidates. The company was founded in 2001 and is based in Australia. Its strategy is to combine cannabinoid drugs with existing therapeutic compounds that have expired